These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25152448)

  • 1. Loss of long term protection with the inclusion of HIV pol to a DNA vaccine encoding gag.
    Garrod TJ; Gargett T; Yu W; Major L; Burrell CJ; Wesselingh S; Suhrbier A; Grubor-Bauk B; Gowans EJ
    Virus Res; 2014 Nov; 192():25-33. PubMed ID: 25152448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccines.
    zur Megede J; Otten GR; Doe B; Liu H; Leung L; Ulmer JB; Donnelly JJ; Barnett SW
    J Virol; 2003 Jun; 77(11):6197-207. PubMed ID: 12743276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cells.
    Payne RP; Kløverpris H; Sacha JB; Brumme Z; Brumme C; Buus S; Sims S; Hickling S; Riddell L; Chen F; Luzzi G; Edwards A; Phillips R; Prado JG; Goulder PJ
    J Virol; 2010 Oct; 84(20):10543-57. PubMed ID: 20686036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of human immunodeficiency virus type 1 subtype C gag, pol, and gagpol DNA and alphavirus replicon vaccines.
    Megede JZ; Otten GR; Doe B; Liu H; Srivastava R; Greer C; Legg H; Tang T; Polo JM; Donnelly JJ; Ulmer JB; Barnett SW
    Vaccine; 2006 Apr; 24(15):2755-63. PubMed ID: 16460840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses.
    Tomusange K; Wijesundara D; Gummow J; Wesselingh S; Suhrbier A; Gowans EJ; Grubor-Bauk B
    Sci Rep; 2016 Nov; 6():36658. PubMed ID: 27853256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides.
    Jiang JQ; Patrick A; Moss RB; Rosenthal KL
    J Virol; 2005 Jan; 79(1):393-400. PubMed ID: 15596832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.
    Rollman E; Mathy N; Bråve A; Boberg A; Kjerrström A; van Wely C; Engström G; Johansson S; Aperia K; Eriksson LE; Benthin R; Ertl P; Heeney J; Hinkula J; Voss G; Wahren B
    Vaccine; 2007 Mar; 25(11):2145-54. PubMed ID: 17254672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C.
    Gómez CE; Nájera JL; Jiménez V; Bieler K; Wild J; Kostic L; Heidari S; Chen M; Frachette MJ; Pantaleo G; Wolf H; Liljeström P; Wagner R; Esteban M
    Vaccine; 2007 Mar; 25(11):1969-92. PubMed ID: 17224219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with a fusion protein that introduces HIV-1 gag antigen into a multitrimer CD40L construct results in enhanced CD8+ T cell responses and protection from viral challenge by vaccinia-gag.
    Gupta S; Termini JM; Raffa FN; Williams CA; Kornbluth RS; Stone GW
    J Virol; 2014 Feb; 88(3):1492-501. PubMed ID: 24227853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic competition in CD4
    Kallas EG; Grunenberg NA; Yu C; Manso B; Pantaleo G; Casapia M; Baden LR; Valencia J; Sobieszczyk M; Van Tieu H; Allen M; Hural J; Graham BS; Kublin J; Gilbert PB; Corey L; Goepfert PA; McElrath MJ; Johnson RP; Huang Y; Frahm N
    Sci Transl Med; 2019 Nov; 11(519):. PubMed ID: 31748227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of T cell responses to chimpanzee adenovirus vectors encoding HIV gag-pol-nef antigen.
    Herath S; Le Heron A; Colloca S; Bergin P; Patterson S; Weber J; Tatoud R; Dickson G
    Vaccine; 2015 Dec; 33(51):7283-7289. PubMed ID: 26546736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of Gag-specific but reduction of Env- and Pol-specific CD8+ T cell responses by simian immunodeficiency virus nonstructural proteins in mice.
    Zhang Y; Sun C; Feng L; Xiao L; Chen L
    AIDS Res Hum Retroviruses; 2012 Apr; 28(4):374-83. PubMed ID: 21736424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient augmentation of a long-lasting immune responses in HIV-1 gag DNA vaccination by IL-15 plasmid boosting.
    Li W; Li S; Hu Y; Tang B; Cui L; He W
    Vaccine; 2008 Jun; 26(26):3282-90. PubMed ID: 18472194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel HIV-1 clade B candidate vaccines designed for HLA-B*5101(+) patients protected mice against chimaeric ecotropic HIV-1 challenge.
    Roshorm Y; Hong JP; Kobayashi N; McMichael AJ; Volsky DJ; Potash MJ; Takiguchi M; Hanke T
    Eur J Immunol; 2009 Jul; 39(7):1831-40. PubMed ID: 19585509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of antigen-positive cell death by the expression of perforin, but not DTa, from a DNA vaccine enhances the immune response.
    Gargett T; Grubor-Bauk B; Garrod TJ; Yu W; Miller D; Major L; Wesselingh S; Suhrbier A; Gowans EJ
    Immunol Cell Biol; 2014 Apr; 92(4):359-67. PubMed ID: 24323081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of HIV Tat DNA on regulating the immune response of HIV DNA vaccine in mice.
    Liu Y; Li F; Qi Z; Hao Y; Hong K; Liu Y; Cong Y; Shao Y
    Virol J; 2013 Sep; 10():297. PubMed ID: 24073803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel HIV IL-4R antagonist vaccine strategy can induce both high avidity CD8 T and B cell immunity with greater protective efficacy.
    Jackson RJ; Worley M; Trivedi S; Ranasinghe C
    Vaccine; 2014 Sep; 32(43):5703-14. PubMed ID: 25151041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of HIV-specific T and B cell responses with a replicating and conditionally infectious lentiviral vaccine.
    Wingard JB; Anderson B; Weissman D
    Eur J Immunol; 2008 May; 38(5):1310-20. PubMed ID: 18412164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA vaccines encoding membrane-bound or secreted forms of heat shock protein 70 exhibit improved potency.
    Garrod TJ; Grubor-Bauk B; Gargett T; Li Y; Miller DS; Yu W; Major L; Burrell CJ; Wesselingh S; Suhrbier A; Gowans EJ
    Eur J Immunol; 2014 Jul; 44(7):1992-2002. PubMed ID: 24723366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.